Evotec SE (EVO) Return on Capital Employed (2009 - 2025)
Evotec SE (EVO) posted Return on Capital Employed of 5.11% for Q4 2025, up 27.12% sequentially from 7.02% in Q3 2025, and down 511.0% YoY from 1.24% in Q4 2024.
Evotec SE (EVO) Return on Capital Employed (2009 - 2025) Analysis & Trends
Evotec SE has reported Return on Capital Employed for 6 years, with the latest figure at 5.11% in Q4 2025.
- Quarterly Return on Capital Employed fell 511.0% year-over-year to 5.11% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 5.11% (down 511.0% YoY) and the FY2025 annual result came in at 0.01%, down 1.0% from the prior year.
- Return on Capital Employed climbed to 5.11% in Q4 2025 per EVO's latest filing, from 7.02% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 0.85% in Q1 2022 and troughed at 7.02% in Q3 2025.
- A 4-year average of 1.89% and a median of 0.03% in 2021 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2025: Return on Capital Employed rose 1 bps in 2022, then sank 511 bps in 2025.
- Over 4 years, Return on Capital Employed stood at 0.03% in 2021, then surged by 41 bps to 0.02% in 2022, then surged by 100 bps to 0.0% in 2024, then tumbled by 115270486 bps to 5.11% in 2025.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 5.11%, 7.02%, and 0.0% for Q4 2025, Q3 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.31 Bn | 43.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.87 Bn | 40.22 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 32.16 Bn | 30.48 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Evotec SE | 681.90 Mn | 681.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.11% |
| Sep 30, 2025 | -7.02% |
| Dec 31, 2024 | 0.00% |
| Dec 31, 2022 | -0.02% |
| Mar 31, 2022 | 0.85% |
| Dec 31, 2021 | -0.03% |
| Sep 30, 2010 | -8,612.36% |
| Jun 30, 2010 | -15.13% |
| Mar 31, 2010 | 26,433,850.85% |
| Jun 30, 2009 | 13,757,199.92% |
| Mar 31, 2009 | 13,312,789.64% |